B
Blackrock Neurotech
Manufactures a wide range of scientific equipment to record bio-potentials from the central and peripheral nervous system in both chronic and acute applications
About Blackrock Neurotech
Blackrock Neurotech is a biotechnology company that develops brain-computer interface (BCI) technology. The company's mission is to provide tools that help people with paralysis and other neurological disorders to communicate and control their environment.
Blackrock Neurotech's main product is the Utah Array, a microelectrode array that is implanted in the brain to record neural signals. The company also provides software and hardware that allow users to decode these signals and use them to control external devices, such as computers and prosthetic limbs. The company's business model is based on selling its BCI systems to research institutions and medical device companies. Blackrock Neurotech also generates revenue from providing engineering and consulting services to its clients.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2008
- Headquarters
- Salt Lake City, United States
- Employees
- 191
- Open positions
- None listed
- Dealroom signal
- 80.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Rehabilitation, Biotechnology, Spinout, Biotech and Pharma, Brain Computer Interfaces, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 2 companies, latest Apr 2022
- Capital deployed
- $3.3M
- Preferred round
- SEED
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VC✓Equity / VC | May 2024 | $12M | — | Undisclosed | ↗ |
| ACQUISITION✓Exit | Apr 2024 | $200M | — | Tether | ↗ |
Growth signals
Latest recorded traffic for Blackrock Neurotech is 21K monthly website visits, up 31.3% over the last three months. Blackrock Neurotech's team grew 19.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Mind-X CorpBethesda, United StatesMind-X Corp combines neurotechnology, augmented reality and artificial intelligence to create a computer interference
→
Phantom NeuroAustin, United StatesCreates a system that will enable lifelike control of robotic orthopedic technologies
$76Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
Peter Thiel
Sorenson Impact Foundation
re.Mind Capital
2050 Capital
Tim Sievers
Presight Capital
Other known investors5 additional known investors
Tether
University of Utah
Ajay Juneja
KLIWLA Family Office
What If Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Blackrock Neurotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Blackrock Neurotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.